Search | Médecins Sans Frontières Access Campaign

58 results found

Statement |

04 February 2020

WHO 146th EB - 10 (EB146/11) – Ending tuberculosis

MSF Statement: Agenda item 10 (EB146/11) – Ending tuberculosis

Tags Research and development drug-resistant TBtuberculosis WHO Executive Board

Events |

20 May 2019

MSF at the 72nd World Health Assembly

Tags Antimicrobial resistanceResearch and developmentTuberculosis drug-resistant TBtuberculosis World Health AssemblyWorld Health Organization

Technical brief |

08 February 2019

Opposing patent application for bedaquiline formulation in India

Tags Intellectual property and tradeTuberculosis drug-resistant TBtuberculosis bedaquiline patent opposition India

A woman dances during a Stop Stock Outs Project activist meeting in Soshanguve, a township outside of Pretoria on April 16, 2015. As a grassroots project, SSP regularly organizes training for people living with HIV in order to equip them on the know how to monitor and report drug shortages.

Press release |

31 May 2018

South Africa takes landmark step for access to medicines

Tags Intellectual property and trade drug-resistant TBtuberculosis access to medicines South Africa

97% of the medicines MSF uses to treat people with HIV are generics made in India.

Infographic

MSF and generic medicines

Tags Intellectual property and trade drug-resistant TBHIV/AIDS free trade agreementgeneric medicinesRegional Comprehensive Economic Partnership (RCEP)

Issue brief |

29 March 2016

The 3P Project - Accelerating Innovation and Access to Medicines for Tuberculosis

Tags Research and development tuberculosisdrug-resistant TB 3PCEWGLife Prizeresearch and development (R&D)

Statement |

27 July 2015

WIPO Standing Committee on the Law of Patents, 22nd Session

Tags Intellectual property and trade drug-resistant TBEbolahepatitis C World Health Organization

Hermenegilda. Albazine’s Health Center. Maputo, Mozambique.

Feature story |

12 June 2015

Stockouts in South Africa: Patient testimonies

Tags Research and development drug-resistant TBtuberculosis antiretroviral medicines access to medicinesstock out

Press release |

10 June 2015

Drug shortages threaten progress made in the world’s largest HIV programme

Tags Intellectual property and trade drug-resistant TBHIV/AIDStuberculosis antiretroviral medicines access to medicinesstock out South Africa

Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB, which includes delamanid and bedaquiline. Khayelitsha, Western Cape, South Africa..

Opinion article |

10 April 2015

TB Patients Take the Stage: Now for an R&D Model That Meets Their Needs

Tags Research and developmentTuberculosis tuberculosisdrug-resistant TB 3PLife Prize

Letter |

12 September 2014

Open letter to Janssen on reducing the price of bedaquiline

Tags Intellectual property and trade drug-resistant TB

Statement |

01 October 2013

MSF response to launch of the “Roadmap for childhood tuberculosis: towards zero deaths”

Tags Intellectual property and tradeTuberculosis tuberculosisdrug-resistant TB

Statement |

13 June 2013

MSF welcomes WHO guidelines on TB drug bedaquiline; but more work needed

Tags Research and developmentTuberculosis drug-resistant TBtuberculosis bedaquiline World Health Organization

Video |

21 March 2013

Test Me, Treat Me: A DR-TB Manifesto

Tags Intellectual property and tradeTuberculosis tuberculosisdrug-resistant TB

MSF Dr. Christoph Hoehn and nurse Gulru Nobodieva examine a nine-month old baby in Dushanbe, Tajikistan.

Feature story |

12 March 2013

Tajikistan: MSF treats its youngest-ever patient for multidrug-resistant TB

Tags Intellectual property and tradeTuberculosis drug-resistant TBtuberculosis Tajikistan

Video |

15 January 2013

New drug offers "real potential" for better treatment options for TB

Tags Intellectual property and tradeTuberculosis drug-resistant TBtuberculosis bedaquiline

Press release |

08 January 2013

Some South African TB patients in dire need to get new US approved TB drug

Tags Intellectual property and tradeTuberculosis drug-resistant TBtuberculosis bedaquiline South Africa

Press release |

31 December 2012

First new tuberculosis drug for 50 years – works on drug-resistant forms of the disease

Tags Intellectual property and tradeResearch and developmentTuberculosis tuberculosisdrug-resistant TB bedaquiline

Video |

17 December 2012

Medicines Shouldn't be a Luxury

Medicines are essential for health and survival. But far too often, they’re priced like luxury items. We’re working to change that.

Tags HIV/AIDSIntellectual property and tradeResearch and developmentTropical & neglected diseasesTuberculosisVaccines drug-resistant TBHIV/AIDSneglected diseasestuberculosis research and development (R&D)

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

WHO 146th EB - 10 (EB146/11) – Ending tuberculosis

MSF at the 72nd World Health Assembly

Opposing patent application for bedaquiline formulation in India

Infographics: our wishlist for 2019

South Africa takes landmark step for access to medicines

MSF and generic medicines

The 3P Project - Accelerating Innovation and Access to Medicines for Tuberculosis

WIPO Standing Committee on the Law of Patents, 22nd Session

Stockouts in South Africa: Patient testimonies

Drug shortages threaten progress made in the world’s largest HIV programme

TB Patients Take the Stage: Now for an R&D Model That Meets Their Needs

Open letter to Janssen on reducing the price of bedaquiline

MSF response to launch of the “Roadmap for childhood tuberculosis: towards zero deaths”

MSF welcomes WHO guidelines on TB drug bedaquiline; but more work needed

Test Me, Treat Me: A DR-TB Manifesto

Tajikistan: MSF treats its youngest-ever patient for multidrug-resistant TB

New drug offers "real potential" for better treatment options for TB

Some South African TB patients in dire need to get new US approved TB drug

First new tuberculosis drug for 50 years – works on drug-resistant forms of the disease

Medicines Shouldn't be a Luxury